Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 655, pseudogene (RNU6-655P) is a processed pseudogene of the U6 small nuclear RNA family found in humans[1]. U6 snRNA pseudogenes are non-coding elements generated by retrotrasposition, often as chimeric sequences joined to LINE-1 elements via an RNA ligation process mediated by the RNA ligase RtcB[3]. These pseudogenes do not encode proteins and generally lack direct biological activity, but may conceivably contribute to transcriptomic regulation or genomic variation. While several pseudogenes are implicated as regulators in cancer and other diseases via ceRNA activity[2], no disease associations or functional studies are documented for RNU6-655P specifically. It is not considered a therapeutic target or clinical biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 655, pseudogene (RNU6-655P).